GRM5 and Huntington disease: This is in line with previous work that shows that mHTT causes the pathological entry of REST/NRSF into the nucleus, leading to a transcriptional repression of its target genes such as SNAP-25 [7–9] and that both pharmacological and genetic ablation of mGluR5 reduces mHTT burden in HD mice [18, 19].